3-deazaneplanocin has been researched along with Kahler Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahu, J; DaCosta, L; Gaudichon, J; Martens, AC; Milano, F; Renoir, JM; Sola, B | 1 |
| Agarwal, P; Atadja, P; Deleu, S; Eriksson, M; Fristedt, C; Fryknäs, M; Jernberg-Wiklund, H; Kalushkova, A; Lemaire, M; Nilsson, K; Oberg, F; Osterborg, A; Vanderkerken, K | 1 |
| Bi, C; Chen, CS; Cheong, LL; Chng, WJ; Huang, G; Liu, SC; Xie, Z; Yu, Q; Zhou, J | 1 |
3 other study(ies) available for 3-deazaneplanocin and Kahler Disease
| Article | Year |
|---|---|
Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche.
Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Interactions; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Mice; Multiple Myeloma; Polycomb Repressive Complex 2; Pyrazines; Syndecan-1; Xenograft Model Antitumor Assays | 2014 |
Polycomb target genes are silenced in multiple myeloma.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Apoptosis; Blotting, Western; Cadherins; Cell Line, Tumor; Cells, Cultured; Chemokine CXCL12; Chromatin Immunoprecipitation; Computational Biology; DNA Methylation; GATA2 Transcription Factor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Interferon Regulatory Factors; Kaplan-Meier Estimate; Mice; Multiple Myeloma; Panobinostat; Polycomb-Group Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.
Topics: Adenosine; Apoptosis; Arachidonate 5-Lipoxygenase; Biphenyl Compounds; Caspases; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Drug Synergism; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Nitrophenols; Piperazines; Polycomb Repressive Complex 2; Sulfonamides; Transcription Factors | 2011 |